June-Wha Rhee
Overview
Explore the profile of June-Wha Rhee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Colville A, Liu J, Rodriguez-Mateo C, Thomas S, Ishak H, Zhou R, et al.
Cell Metab
. 2023 Sep;
35(10):1814-1829.e6.
PMID: 37699398
Selectively ablating damaged cells is an evolving therapeutic approach for age-related disease. Current methods for genome-wide screens to identify genes whose deletion might promote the death of damaged or senescent...
12.
Thiruvengadam S, Herrera A, Rhee J
JACC CardioOncol
. 2023 Jul;
5(3):281-291.
PMID: 37397077
Anthracycline-containing therapy is the cornerstone of frontline treatment for diffuse large B-cell lymphoma (DLBCL), and autologous stem cell transplantation, and more recently, chimeric antigen receptor T-cell therapy are the primary...
13.
Kim J, Freeman K, Ayala A, Mullen M, Sun Z, Rhee J
Curr Oncol Rep
. 2023 Jun;
25(9):965-977.
PMID: 37273124
Purpose Of The Review: There have been increasing reports of cardiovascular complications of androgen deprivation therapy (ADT) leading to worse outcomes among patients with prostate cancer. While this may result...
14.
Wei C, Fazal M, Loh A, Kapoor R, Gomez S, Shah S, et al.
J Interv Card Electrophysiol
. 2023 May;
67(1):111-118.
PMID: 37256462
Background: Tyrosine kinase inhibitors (TKIs) are widely used in the treatment of hematologic malignancies. Limited studies have shown an association between treatment-limiting arrhythmias and TKI, particularly ibrutinib, a Bruton's tyrosine...
15.
Ghigo A, Meijers W, Rhee J, Ameri P
Front Physiol
. 2023 May;
14:1205810.
PMID: 37228811
No abstract available.
16.
Tang X, Lai C, Malhi N, Chadha R, Luo Y, Liu X, et al.
Noncoding RNA
. 2023 May;
9(3).
PMID: 37218991
(1) Background: Hypertension is a complex, multifactorial disease that is caused by genetic and environmental factors. Apart from genetic predisposition, the mechanisms involved in this disease have yet to be...
17.
Lee K, Lindenfeld L, Echevarria M, Hsu J, Wong F, Narayan H, et al.
Int J Cardiol
. 2023 Mar;
380:40-46.
PMID: 36958393
Background: Tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Emerging data suggest that these agents can result in clinically...
18.
Deng J, Jiang Y, Chen Z, Rhee J, Deng Y, Wang Z
Cells
. 2023 Mar;
12(5).
PMID: 36899814
Electrophysiological and structural disruptions in cardiac arrhythmias are closely related to mitochondrial dysfunction. Mitochondria are an organelle generating ATP, thereby satisfying the energy demand of the incessant electrical activity in...
19.
Currie J, Manda V, Robinson S, Lai C, Agnihotri V, Hidalgo V, et al.
bioRxiv
. 2023 Jan;
PMID: 36711879
The functions of proteins depend on their spatial and temporal distributions, which are not directly measured by static protein abundance. Under endoplasmic reticulum (ER) stress, the unfolded protein response (UPR)...
20.
Tyrosine kinase inhibitor-associated ventricular arrhythmias: a case series and review of literature
Fazal M, Wei C, Lee Chuy K, Hussain K, Gomez S, Ba S, et al.
J Interv Card Electrophysiol
. 2022 Nov;
66(5):1165-1175.
PMID: 36411365
Background: Tyrosine kinase inhibitors (TKIs) have been increasingly used as first-line therapy in hematologic and solid-organ malignancies. Multiple TKIs have been linked with the development of cardiovascular complications, especially atrial...